Clinical Trial Update: Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a bone maintenance algorithm using a bisphosphonate in combination with Anastrozole for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Barwon Health | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED